Transdermal contraceptive patch--a new birth control option.
Banerjee
S
S
Canadian Coordinating Office for Health Technology Assessment.
D000279:Administration, Cutaneous; D002170:Canada; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010349:Patient Compliance; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D013673:Technology Assessment, Biomedical; D014481:United States
D003271:Contraceptive Agents, Female; D003277:Contraceptives, Oral, Combined